Lista de obras -

A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis

artículo científico publicado en 2010

Abnormal effective connectivity and psychopathological symptoms in the psychosis high-risk state

artículo científico publicado en 2014

Abnormal functional integration of thalamic low frequency oscillation in the BOLD signal after acute heroin treatment

artículo científico publicado en 2015

Age of second language acquisition in multilinguals has an impact on gray matter volume in language-associated brain areas

artículo científico publicado en 2015

Anterior cingulate pathology in the prodromal stage of schizophrenia

artículo científico publicado en 2007

Association of brain volume loss and long-term disability outcomes in patients with multiple sclerosis treated with teriflunomide

artículo científico publicado en 2019

Association of frontal gray matter volume and cerebral perfusion in heroin addiction: a multimodal neuroimaging study

artículo científico publicado en 2013

Cavum septum pellucidum in patients with first episode psychosis and individuals at high risk of psychosis

artículo científico publicado en 2007

Cerebellar abnormalities contribute to disability including cognitive impairment in multiple sclerosis

artículo científico publicado en 2014

Classifying individuals at high-risk for psychosis based on functional brain activity during working memory processing

artículo científico publicado en 2015

Comparison between balanced steady-state free precession and standard spoiled gradient echo magnetization transfer ratio imaging in multiple sclerosis: methodical and clinical considerations

artículo científico publicado en 2014

Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis.

artículo científico publicado en 2013

Correlation between brain volume loss and clinical and MRI outcomes in multiple sclerosis

artículo científico publicado en 2015

Different duration of at-risk mental state associated with neurofunctional abnormalities. A multimodal imaging study

artículo científico publicado en 2011

Effects of cannabis on impulsivity: a systematic review of neuroimaging findings

artículo científico publicado en 2014

Evaluation of a new approach for semi-automatic segmentation of the cerebellum in patients with multiple sclerosis

artículo científico publicado en 2012

Health-related quality of life in multiple sclerosis: effects of natalizumab

artículo científico publicado en 2007

Hippocampal volume correlates with attenuated negative psychotic symptoms irrespective of antidepressant medication

artículo científico publicado en 2015

Hippocampal volume in subjects at high risk of psychosis: a longitudinal MRI study

artículo científico publicado en 2012

Hippocampal volume reduction specific for later transition to psychosis or substance-associated effects?

artículo científico publicado en 2010

Hippocampus abnormalities in at risk mental states for psychosis? A cross-sectional high resolution region of interest magnetic resonance imaging study

artículo científico publicado en 2009

Impact of fingolimod therapy on magnetic resonance imaging outcomes in patients with multiple sclerosis

artículo científico

Insular pathology in the at-risk mental state.

artículo científico publicado en 2008

Label-fusion-segmentation and deformation-based shape analysis of deep gray matter in multiple sclerosis: the impact of thalamic subnuclei on disability

artículo científico publicado en 2014

Lesion-to-ventricle distance and other risk factors for the persistence of newly formed black holes in relapsing-remitting multiple sclerosis

artículo científico publicado en 2013

Long-term effects of fingolimod in multiple sclerosis: the randomized FREEDOMS extension trial

artículo científico publicado en 2015

Magnetization transfer ratio in lesions rather than normal-appearing brain relates to disability in patients with multiple sclerosis

artículo científico publicado en 2015

Multivariate pattern classification of gray matter pathology in multiple sclerosis

artículo científico publicado en 2012

Natalizumab plus interferon beta-1a for relapsing multiple sclerosis

artículo científico publicado en 2006

Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis

artículo científico publicado en 2010

Neuromyelitis optica: clinical manifestations and neuroimaging features

artículo científico publicado en 2013

No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT.

artículo científico publicado en 2015

Pathology of immune reconstitution inflammatory syndrome in multiple sclerosis with natalizumab-associated progressive multifocal leukoencephalopathy

artículo científico publicado en 2011

Progression in disability and regional grey matter atrophy in relapsing–remitting multiple sclerosis

artículo científico publicado en 2013

Reduced volume of the nucleus accumbens in heroin addiction

artículo científico publicado en 2014

Reductions in frontal, temporal and parietal volume associated with the onset of psychosis.

artículo científico publicado en 2008

Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial

artículo científico publicado en 2014

Sodium intake and multiple sclerosis activity and progression in BENEFIT.

artículo científico publicado en 2017

Spatiotemporal distribution of white matter lesions in relapsing-remitting and secondary progressive multiple sclerosis

artículo científico publicado en 2012

Structural brain abnormalities in individuals with an at-risk mental state who later develop psychosis

artículo científico publicado en 2007

Subcortical brain segmentation of two dimensional T1-weighted data sets with FMRIB's Integrated Registration and Segmentation Tool (FIRST).

artículo científico publicado en 2014

Switching from natalizumab to fingolimod: A randomized, placebo-controlled study in RRMS

artículo científico publicado en 2015

The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL.

artículo científico publicado en 2009

The role of cerebellar abnormalities in neuromyelitis optica--a comparison with multiple sclerosis and healthy controls

artículo científico publicado en 2014

White matter lesion filling improves the accuracy of cortical thickness measurements in multiple sclerosis patients: a longitudinal study

artículo científico publicado en 2014

Lista de obras de

A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis

Abnormal effective connectivity and psychopathological symptoms in the psychosis high-risk state

Abnormal functional integration of thalamic low frequency oscillation in the BOLD signal after acute heroin treatment

Age of second language acquisition in multilinguals has an impact on gray matter volume in language-associated brain areas

Anterior cingulate pathology in the prodromal stage of schizophrenia

Association of brain volume loss and long-term disability outcomes in patients with multiple sclerosis treated with teriflunomide

Association of frontal gray matter volume and cerebral perfusion in heroin addiction: a multimodal neuroimaging study

Cavum septum pellucidum in patients with first episode psychosis and individuals at high risk of psychosis

Cerebellar abnormalities contribute to disability including cognitive impairment in multiple sclerosis

Classifying individuals at high-risk for psychosis based on functional brain activity during working memory processing

Comparison between balanced steady-state free precession and standard spoiled gradient echo magnetization transfer ratio imaging in multiple sclerosis: methodical and clinical considerations

Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis.

Correlation between brain volume loss and clinical and MRI outcomes in multiple sclerosis

Different duration of at-risk mental state associated with neurofunctional abnormalities. A multimodal imaging study

Effects of cannabis on impulsivity: a systematic review of neuroimaging findings

Evaluation of a new approach for semi-automatic segmentation of the cerebellum in patients with multiple sclerosis

Health-related quality of life in multiple sclerosis: effects of natalizumab

Hippocampal volume correlates with attenuated negative psychotic symptoms irrespective of antidepressant medication

Hippocampal volume in subjects at high risk of psychosis: a longitudinal MRI study

Hippocampal volume reduction specific for later transition to psychosis or substance-associated effects?

Hippocampus abnormalities in at risk mental states for psychosis? A cross-sectional high resolution region of interest magnetic resonance imaging study

Impact of fingolimod therapy on magnetic resonance imaging outcomes in patients with multiple sclerosis

Insular pathology in the at-risk mental state.

Label-fusion-segmentation and deformation-based shape analysis of deep gray matter in multiple sclerosis: the impact of thalamic subnuclei on disability

Lesion-to-ventricle distance and other risk factors for the persistence of newly formed black holes in relapsing-remitting multiple sclerosis

Long-term effects of fingolimod in multiple sclerosis: the randomized FREEDOMS extension trial

Magnetization transfer ratio in lesions rather than normal-appearing brain relates to disability in patients with multiple sclerosis

Multivariate pattern classification of gray matter pathology in multiple sclerosis

Natalizumab plus interferon beta-1a for relapsing multiple sclerosis

Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis

Neuromyelitis optica: clinical manifestations and neuroimaging features

No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT.

Pathology of immune reconstitution inflammatory syndrome in multiple sclerosis with natalizumab-associated progressive multifocal leukoencephalopathy

Progression in disability and regional grey matter atrophy in relapsing–remitting multiple sclerosis

Reduced volume of the nucleus accumbens in heroin addiction

Reductions in frontal, temporal and parietal volume associated with the onset of psychosis.

Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial

Sodium intake and multiple sclerosis activity and progression in BENEFIT.

Spatiotemporal distribution of white matter lesions in relapsing-remitting and secondary progressive multiple sclerosis

Structural brain abnormalities in individuals with an at-risk mental state who later develop psychosis

Subcortical brain segmentation of two dimensional T1-weighted data sets with FMRIB's Integrated Registration and Segmentation Tool (FIRST).

Switching from natalizumab to fingolimod: A randomized, placebo-controlled study in RRMS

The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL.

The role of cerebellar abnormalities in neuromyelitis optica--a comparison with multiple sclerosis and healthy controls

White matter lesion filling improves the accuracy of cortical thickness measurements in multiple sclerosis patients: a longitudinal study